Institutional shares held 76.1 Million
5.06M calls
7.19M puts
Total value of holdings $1.1B
$72.9M calls
$103M puts
Market Cap $1.13B
78,215,104 Shares Out.
Institutional ownership 97.3%
# of Institutions 241


Latest Institutional Activity in NVAX

Top Purchases

Q1 2024
Coatue Management LLC Shares Held: 1.52M ($21.9M)
Q1 2024
Farallon Capital Management LLC Shares Held: 1.13M ($16.3M)
Q1 2024
Black Rock Inc. Shares Held: 9.43M ($136M)
Q1 2024
Ubs Group Ag Shares Held: 995K ($14.3M)
Q1 2024
Allianz Asset Management Gmb H Shares Held: 1.47M ($21.2M)

Top Sells

Q1 2024
Morgan Stanley Shares Held: 1.87M ($26.9M)
Q1 2024
Vanguard Group Inc Shares Held: 13.5M ($194M)
Q1 2024
Jane Street Group, LLC Shares Held: 91.7K ($1.32M)
Q1 2024
Barclays PLC Shares Held: 253K ($3.65M)
Q1 2024
Millennium Management LLC Shares Held: 26.2K ($378K)

About NVAX

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.


Insider Transactions at NVAX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
251K Shares
From 13 Insiders
Exercise of conversion of derivative security 251K shares
Sell / Disposition
143K Shares
From 7 Insiders
Payment of exercise price or tax liability 95.5K shares
Open market or private sale 47.3K shares

Track Institutional and Insider Activities on NVAX

Follow NOVAVAX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

News

Receive news related to NOVAVAX INC

Track Activities on NVAX